ArticleUltrasonography (Seoul, Korea)2026
BI-RADS v2025 for breast ultrasound: key updates and Asian perspectives.
Article in Ultrasonography (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Breast ultrasound plays an increasingly important role in breast cancer detection, diagnosis, and management, particularly in regions where mammographic sensitivity is reduced by dense breast tissue. Although the Breast Imaging Reporting and Data System (BI-RADS) lexicon, developed by the American College of Radiology, provides a standardized framework for ultrasound interpretation, its terminology and conceptual structure continue to evolve in response to advances in imaging technology, changes in screening paradigms, and ongoing refinement of diagnostic and therapeutic approaches. This review summarizes the key ultrasound-related updates in BI-RADS v2025, with particular emphasis on the glandular tissue component, non-mass lesions, and structured lymph node assessment, and discusses their clinical implications in settings where breast ultrasound plays a central role in screening and diagnostic pathways, especially in Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.